Your fact-checks will appear here
The use of PSMA PET to guide salvage radiotherapy in prostate cancer patients, including outcomes and ongoing trials.
Multiparametric MRI (mpMRI) is a valuable, often first-line imaging tool to distinguish benign residual prostate tissue, post‑operative fibrosis, and local tumor recurrence after radical prostatectomy...
For localizing prostate cancer recurrence specifically within the prostatectomy bed, multiparametric MRI (mpMRI) remains the favored tool for high-resolution anatomic localization while PSMA PET/CT ad...
Multiparametric MRI (mpMRI) is a powerful tool for localizing recurrence after radical prostatectomy, but its sensitivity is strongly influenced by the absolute PSA at biochemical recurrence and by PS...
After radical prostatectomy, PSA is expected to fall to undetectable levels within weeks to months, and guidelines generally advise the first postoperative PSA check at about 6–8 weeks; thereafter mos...
Three categories of randomized trials are actively testing whether PSMA PET–guided changes to salvage radiotherapy improve outcomes: a completed/phase‑II randomized study reported in meetings with a f...